CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 189 filers reported holding CARA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,301,136 | -38.3% | 774,486 | +4.0% | 0.00% | 0.0% |
| Q2 2023 | $2,107,889 | +3455455.7% | 744,837 | +5855.4% | 0.00% | – |
| Q1 2023 | $61 | -69.0% | 12,507 | -31.7% | 0.00% | – |
| Q4 2022 | $197 | -100.0% | 18,317 | -97.6% | 0.00% | -100.0% |
| Q2 2022 | $7,105,000 | +1175.6% | 778,186 | +2058.0% | 0.00% | – |
| Q3 2021 | $557,000 | -74.8% | 36,061 | -64.6% | 0.00% | -100.0% |
| Q1 2021 | $2,212,000 | -13.2% | 101,908 | -39.5% | 0.00% | 0.0% |
| Q4 2020 | $2,547,000 | +1347.2% | 168,313 | +1116.7% | 0.00% | – |
| Q3 2020 | $176,000 | -90.3% | 13,833 | -87.0% | 0.00% | -100.0% |
| Q2 2020 | $1,815,000 | +184.0% | 106,154 | +167.4% | 0.00% | +100.0% |
| Q4 2019 | $639,000 | -47.5% | 39,694 | -29.9% | 0.00% | -50.0% |
| Q2 2019 | $1,217,000 | +143.4% | 56,607 | +122.0% | 0.00% | +100.0% |
| Q1 2019 | $500,000 | -87.8% | 25,497 | -91.9% | 0.00% | -83.3% |
| Q4 2018 | $4,086,000 | -47.0% | 314,345 | -2.3% | 0.01% | -33.3% |
| Q3 2018 | $7,706,000 | +120.0% | 321,760 | +75.9% | 0.01% | +125.0% |
| Q2 2018 | $3,503,000 | +9.1% | 182,897 | -30.3% | 0.00% | -20.0% |
| Q4 2017 | $3,210,000 | +1111.3% | 262,222 | +1253.0% | 0.01% | – |
| Q3 2017 | $265,000 | -93.5% | 19,381 | -92.7% | 0.00% | -100.0% |
| Q2 2017 | $4,083,000 | +2586.2% | 265,335 | +1520.7% | 0.01% | – |
| Q4 2016 | $152,000 | -92.8% | 16,372 | -96.3% | 0.00% | -100.0% |
| Q2 2016 | $2,124,000 | -12.7% | 441,620 | +12.9% | 0.01% | -16.7% |
| Q1 2016 | $2,432,000 | -81.5% | 391,045 | -49.9% | 0.01% | -78.6% |
| Q4 2015 | $13,172,000 | +12.1% | 781,255 | -5.0% | 0.03% | +21.7% |
| Q3 2015 | $11,752,000 | +28.5% | 822,400 | +9.2% | 0.02% | +27.8% |
| Q2 2015 | $9,147,000 | +306.4% | 752,822 | +236.1% | 0.02% | +350.0% |
| Q1 2015 | $2,251,000 | +530.5% | 223,978 | +525.5% | 0.00% | +300.0% |
| Q4 2014 | $357,000 | – | 35,809 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
| Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
| Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
| DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
| Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
| Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
| Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |